Micafungin Accordpharma

Micafungin, the active ingredient in Micafungin Accordpharma, is an echinocandin presented as an injection for intravenous use. It treats invasive candidiasis, esophageal candidiasis, and is used for prophylaxis of Candida infections in hematopoietic stem cell transplantation, and may be used off‑label for invasive aspergillosis in certain regions.

GNH USA supplies Micafungin Accordpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Micafungin is an echinocandin antifungal that inhibits fungal cell wall synthesis, and is indicated for several serious fungal infections. - Invasive candidiasis: treatment of bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: eradication of Candida infection of the esophagus. - Prophylaxis of Candida infections in hematopoietic stem cell transplantation: prevention of invasive candidiasis in transplant recipients. - Invasive aspergillosis (off‑label): may be used in selected cases where standard therapy is unsuitable.

Micafungin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Infusion‑related reactions: flushing, rash, or mild hypotension. - Gastrointestinal disturbances: nausea, vomiting, or abdominal pain. - Elevated liver enzymes: transient increase in ALT or AST. - Headache: mild to moderate intensity.

Serious or Rare Side Effects: - Severe hypersensitivity: anaphylaxis or angioedema. - Hepatotoxicity: marked elevation of liver enzymes or jaundice. - Hematologic abnormalities: neutropenia or thrombocytopenia. - Renal impairment: acute kidney injury.

When using Micafungin, clinicians should consider several safety precautions to minimize risk. - Renal function: assess baseline kidney function and monitor during therapy. - Hepatic function: evaluate liver enzymes before initiation and periodically thereafter. - Concomitant antifungals: avoid combining with other agents that may increase hepatotoxicity. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Pediatric use: dosing and safety have not been fully established; use under specialist guidance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Cyclosporine: increased cyclosporine levels; avoid co‑administration. - Rifampin: reduced micafungin exposure; avoid concurrent use.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., fluconazole, voriconazole): may increase micafungin concentrations; monitor liver function. - Warfarin: potential alteration of anticoagulant effect; check INR regularly. - Immunosuppressants (e.g., tacrolimus): possible increased levels; adjust dose as needed.